Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues.
Grayston
J T
JT
University of Washington, Seattle, USA.
Jackson
L A
LA
Kennedy
W J
WJ
Kronmal
R A
RA
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002690:Chlamydia Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae / Q000472:pathogenicity*; D002986:Clinical Trials as Topic / Q000379:methods*; D003327:Coronary Disease / Q000097:blood / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D015337:Multicenter Studies as Topic; D018579:Patient Selection; D010865:Pilot Projects; D012107:Research Design; D013997:Time Factors
D000900:Anti-Bacterial Agents; D015415:Biomarkers